Ledger.Open graph →
SEC Form D · filed October 11, 2022

Treeline Biosciences, Inc

Offering
$269.3M
Sold
$261.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
STAMFORD, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Ali H. Satvat · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorKristina H. Burow · Stamford, CTDirectorDavid H. Schenkein · Stamford, CTDirectorJeffrey H. Engelman · Stamford, CTExec · Director · PromoterJoshua H. Bilenker · Stamford, CTExec · Director · PromoterDavid H. Bonita · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorSteven H. Elms · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorAli H. Satvat · Stamford, CTDirectorAvi H. Naider · Stamford, CTDirectorKristina H. Burow · Stamford, CTDirectorDavid H. Schenkein · Stamford, CTDirectorJeffrey H. Engelman · Stamford, CTExec · Director · PromoterJoshua H. Bilenker · New York, NYExec · Director · PromoterDavid H. Bonita · Stamford, CTDirectorAftab H. Kherani · Stamford, CTDirectorSteven H. Elms · Stamford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗